NIH ME/CFS Telebriefing
![](https://solvecfs.org/wp-content/uploads/2022/08/Webinars-1-1024x1024.png)
NIH’s next ME/CFS telebriefing will be held on August 26, 2022 from 3:00- 4:00 pm ET. The telebriefing will include updates from NIH on ME/CFS-related research activities and a presentation […]
Solve M.E. Spearheads the First Nationwide Long Covid PSA campaign
![](https://solvecfs.org/wp-content/uploads/2022/08/How-Long-Square-1024x1024.png)
We are excited to announce a new program being introduced by Solve M.E. and invite our community play an important part in its roll out. Solve M.E. is on the […]
World ME Alliance Members “Do Not Endorse the Lightning Process”
![World ME Alliance "The Lightning Process: A Position Paper"](https://solvecfs.org/wp-content/uploads/2022/08/Webinars-1024x1024.png)
This article was first published by our friends at the World ME Alliance. Read it here. The World ME Alliance and its members have worked closely over the past few […]
CureME’s Caroline Kingdon on Representing People with Severe ME in Research
![](https://solvecfs.org/wp-content/uploads/2022/08/caroline_kingdon.jpeg)
Caroline Kingdon, RN, MSc, is a research nurse for CureME, an organization at the forefront of participatory epidemiological, clinical and laboratory research into ME/CFS in the UK. She is also […]
Solve M.E. Welcomes Chief Operating Officer TaKeisha S. Walker
Solve M.E. is pleased to announce that TaKeisha S. Walker recently joined us as chief operating officer. In this newly-created role reporting to CEO Oved Amitay, TaKeisha will lead Solve’s […]
CDMRP Program at Department of Defense Announces $1.6M Grant for ME/CFS Research
![CDMRP $1.6 Million](https://solvecfs.org/wp-content/uploads/2022/06/Secures-1.6-Million-in-Funding-1024x954.png)
At Solve M.E., our advocacy team is dedicated to opening new funding avenues for ME/CFS, Long Covid, and post-infection disease research and care. We’re excited to share that our efforts […]
Tracking of ME/CFS Cases in the Revised US ICD-10-CM
![#CountUsCodeUsCureUs](https://solvecfs.org/wp-content/uploads/2022/06/Screen-Shot-2022-06-13-at-15.50.44-1024x1013.png)
Since 2015, the 1-2.5 million Americans with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have been effectively nonexistent, at least as far as US disease tracking systems are concerned. Americans don’t experience […]
Long Haul Voices Episode Two Available Worldwide!
![Man Smiles next to on-screen text that reads "Long Haul Research & Care"](https://solvecfs.org/wp-content/uploads/2022/06/Worldwide-Premiere-1024x1024.png)
The second episode of our three-part video series, Long Haul Voices, is available to view online now! In this episode, we highlight the voices of prominent medical professionals, scientists, and […]
Solve M.E. Research Team at IACFS/ME 2022 Conference
![Research team at IACFSME](https://solvecfs.org/wp-content/uploads/2022/06/Webinars-3-1024x1024.png)
Join Solve M.E.’s research team at this year’s IACFS/ME for a special presentation by Solve M.E.’s Kate Mudie, as well as a poster session, during the 2022 Virtual Scientific Conference […]
Is There a Herpesviruses-Related Antibody Signature In Patients With ME/CFS?
![Nuno Webinar Graphic](https://solvecfs.org/wp-content/uploads/2022/06/Nuno-Webinar-Graphic-1024x1024.png)
Many patients with ME/CFS experience common herpesviruses infections at their disease onset. Alternatively, others experience reactivation of the same infections during the disease course. These facts suggest the existence of […]
2022 INIM Conference
![2022 INIM Conference](https://solvecfs.org/wp-content/uploads/2022/05/2022-INIM-Conference-1024x576.jpeg)
Join the Institute for Neuro-Immune Medicine (Nova Southeastern University) on Friday, June 10th for their annual 2022 INIM Conference. The Institute’s clinicians and researchers will discuss research and the various […]
AIM ImmunoTech Announces Update on Ampligen Long Covid Development Program
![Aim Immunotech Logo](https://solvecfs.org/wp-content/uploads/2022/05/Aim-Immunotech-Logo.jpeg)
Today, AIM ImmunoTech, an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, provided an update […]